Skip to main content
Dan Zandberg, MD, Oncology, Pittsburgh, PA, UPMC Magee-Womens Hospital

DanPaulZandbergMD

Oncology Pittsburgh, PA

Assistant Professor, Medicine, University of Maryland School of Medicine

Dr. Zandberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Zandberg's full profile

Already have an account?

Education & Training

  • University of Maryland
    University of MarylandFellowship, Hematology and Medical Oncology, 2009 - 2012
  • George Washington University
    George Washington UniversityResidency, Internal Medicine, 2005 - 2008
  • Sidney Kimmel Medical College at Thomas Jefferson University
    Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2005

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2018 - 2024
  • MD State Medical License
    MD State Medical License 2012 - 2019
  • VA State Medical License
    VA State Medical License 2005 - 2010
  • DC State Medical License
    DC State Medical License 2005 - 2008
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Intratumor Genetic Heterogeneity in Squamous Cell Carcinoma of the Oral Cavity  
    Scott E Strome, John C Papadimitriou, Dan P Zandberg, Head & Neck

Lectures

  • Definitive cetuximab-based (CRT-CX) vs. non-cetuximab based chemoradiation (CRT) in older patients with squamous cell carcinoma of the head and neck (HNSCC): Analysis ... 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018

Press Mentions

  • OmniSeq and UPMC Collaborate to Launch Novel Phase II Prospective Head and Neck Cancer Clinical Study
    OmniSeq and UPMC Collaborate to Launch Novel Phase II Prospective Head and Neck Cancer Clinical StudyJanuary 28th, 2021
  • Hill Day Advocates Present Unified Voice in Support of NIH, NCI Funding
    Hill Day Advocates Present Unified Voice in Support of NIH, NCI FundingMay 1st, 2019
  • Gene-Guided Immunotherapy Misses Mark in Recurrent/Metastatic Head and Neck Cancer
    Gene-Guided Immunotherapy Misses Mark in Recurrent/Metastatic Head and Neck CancerMarch 5th, 2024
  • Join now to see all

Professional Memberships

Hospital Affiliations